对于数百万依赖 CPAP 呼吸机治疗睡眠呼吸暂停的美国人来说，飞利浦 (Philips) 呼吸机大规模召回事件已从健康危机演变为一场漫长的法律博赔。截至 2026 年 5 月，涉及 1500 万台设备的诉讼已进入关键的赔偿金发放阶段。由 Todd Becker 律师领导的 Becker Law Group (贝克法律集团) 始终致力于保护受害者的合法权益。我们的宗旨是：“您的抗争，就是我们的抗争”，确保您在复杂的法律程序中获得应有的正义。

为什么飞利浦 CPAP 呼吸机会被召回？

召回的核心原因是这些设备中使用的 PE-PUR（聚酯型聚氨酯）消音棉存在缺陷。随着时间的推移，这种泡沫会降解成肉眼可见的黑色微粒，或释放出有毒的挥发性有机化合物 (VOCs)。患者吸入这些物质后，可能导致严重的呼吸道炎症、器官损伤甚至癌症。根据 2024 年与美国司法部 (DOJ) 和 FDA 达成的同意令，飞利浦已被禁止在美销售新的 CPAP 设备，直到其完成所有安全整改。  

2026 年 11 亿美元和解协议的最新进展

目前，位于宾夕法尼亚西区联邦法院的 MDL 3014 案件已进入理赔款发放阶段：

• 人身伤害赔偿： 设立了 10.75 亿美元的基金，用于补偿因接触有毒泡沫而患上呼吸道疾病或癌症的患者。赔偿金将根据伤害的严重程度按积分制进行分配。
• 经济损失补偿： 另有 4.79 亿美元用于补偿用户购买新机器的费用和旧机器的贬值损失。
• 医疗监测： 法院批准了 2500 万美元用于资助为期 15 年的长期健康监测项目，为已暴露但尚未出现症状的患者提供定期筛查。

我现在还能申请理赔吗？

虽然大部分理赔申请窗口已于 2025 年 1 月 31 日关闭，但根据加州法律中的“发现规则” (Discovery Rule)，如果您是在近期才发现疾病与呼吸机之间的因果关系，仍可能拥有法律追溯权。贝克法律集团拥有精通中文的专业律师团队，我们将协助您进行详尽的病历审计，确保您不会因错失截止日期而失去获得公正赔偿的机会。

CPAP Machine Recalls: Navigating Legal Recourse and Patient Safety in 2026

For over five million Americans, a CPAP machine is a life-sustaining necessity for managing sleep apnea. However, the historic Philips Respironics recall—which initially impacted 15 million devices worldwide—has transformed a health solution into a source of long-term medical anxiety. At Becker Law Group, led by Todd Becker, we are dedicated to helping victims navigate the complex aftermath of this crisis. As of May 2026, the litigation has entered a critical disbursement phase, and understanding your rights is essential to "protecting what you've built"—including your health and future security.

What Triggered the Massive CPAP Recalls?

The primary recall centered on the polyester-based polyurethane (PE-PUR) sound abatement foam used in millions of Philips DreamStation and other respiratory devices. Over time, this foam can degrade into black particles or emit toxic Volatile Organic Compounds (VOCs) directly into the user’s air pathway. Inhalation or ingestion of these substances has been linked to severe respiratory inflammation, organ damage, and various forms of cancer. Under the 2024–2026 Consent Decree with the DOJ and FDA, Philips has been prohibited from selling new CPAP and BiPAP devices in the U.S. until it meets stringent safety and remediation benchmarks.

What is the Status of the $1.1 Billion Settlement in 2026?

As of May 2026, the MDL 3014 (consolidated in the Western District of Pennsylvania) has moved into the active distribution of funds. Following the Master Settlement Agreement:

• Personal Injury Claims: A $1.075 billion fund has been established to compensate individuals who suffered respiratory injuries, lung damage, or cancer. Payouts are being distributed based on a points-based system reflecting injury severity.
• Economic Loss Claims: A separate $479 million framework was finalized to reimburse users for device replacement costs and diminished value.
• Medical Monitoring: The court has approved $25 million to fund a 15-year health surveillance program, providing regular screenings for exposed individuals who have not yet developed symptoms.

Are There Any Deadlines I Should Know About?

It is critical to note that the primary registration windows for the $1.1 billion personal injury settlement officially closed on January 31, 2025. However, under the Discovery Rule, individuals who only recently discovered a link between their illness and the recalled device may still have legal avenues. At Becker Law Group, we provide a forensic audit of your medical history to determine if you qualify for late-entry claims or if your case falls under specific state-level exceptions.

How Can I Ensure My Replacement Device is Safe?

Philips has reported that over 99% of registered recalled devices in the U.S. have been remediated as of early 2026. Most replacement or refurbished units now use a silicone-based foam instead of the hazardous PE-PUR foam. If you have received a replacement, verify the serial number through the Philips online portal. If you experience new symptoms—such as chronic cough, sinus infections, or chest pressure—consult your physician immediately. Becker Law Group remains your steadfast advocate, ensuring that corporate accountability follows through every step of your recovery.